Description: SeaStar Medical Holding Corporation, a medical device company, develops cytopheresis systems for addressing inflammation-based diseases and conditions. The company focuses on acute renal failure, end-stage renal disease, and acute inflammation induced by cardiopulmonary bypass surgery. It develops products based on the configurations of commercially available hollow fiber dialysis filters that are used in a proprietary manner to sequester and deactivate leukocytes in the patient's blood system. The company was founded in 1994 and is based in Denver, Colorado.
Home Page: www.seastarmedical.com
ICU Technical Analysis
3513 Brighton Boulevard
Denver,
CO
80216
United States
Phone:
844 427 8100
Officers
| Name | Title |
|---|---|
| Mr. Eric Schlorff | CEO, Pres & Director |
| Dr. H. David Humes M.D. | Co-Founder and Managing Director |
| Ms. Caryl Baron | Interim Chief Financial Officer |
| Tom Mullen | VP of Operations & Product Devel. |
| Colonel Kevin Chung FACP, M.D. | Chief Medical Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2022-10-28 |
| Fiscal Year End: | December |
| Full Time Employees: | 8 |